Key clinical point: Two-thirds of neurologists report having at least one patient who has undergone stem cell therapy.
Major finding: Nearly all respondents (91%) said they have been approached by patients with incurable conditions seeking information about stem cells (37% of whom had diagnosis of multiple sclerosis).
Study details: A survey of 204 academic neurologists in the United States.
Disclosures: The researchers reported having no financial disclosures.
Rai W et al. ACTRIMS Forum 2019, Poster 237.